AL5300

AL5300 Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name AL5300
Generic AL5300
Type
Formula C11H12N2O5S4
Weight Average: 380.483
Monoisotopic: 379.962904264
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
AL5300
AL5300

Innovators Monograph

You find simplified version here AL5300



https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:40728
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4369103
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46509167
https://www.chemspider.com/Chemical-Structure.3571819.html
https://zinc.docking.org/substances/ZINC000003870875
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/AL3
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

RH-1
Apstatin
9-Deazahypoxanthine
(2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-oxo-3-piperidinyl beta-D-glucopyranoside
Balanol
Deamido-Nad+
N'-[4-(2,4-Dimethyl-1,3-thiazol-5-yl)-2-pyrimidinyl]-N-hydroxyimidoformamide
2-Amino-Adenosine
3-Methylcytosine
N-Heptylformamide
Newborn screening tests
PTEN Genetic Test
Donath-Landsteiner test
Hematocrit Test
Necrobiosis lipoidica diabeticorum
CA-125 blood test
Chymotrypsin in Stool
Chest CT
Hemoglobin electrophoresis
PBG urine test
Pulmonary Hypertension (PH)
Hypophysectomy
Eye Pain
Fibrocystic Disease of Breast
Unresectable gastrointestinal origin Progressive Neuroendocrine Tumors
Postoperative paralytic ileus
Pre-operative Gas
Hyperuricemia
Hepatic Insufficiency
Locally advanced disease has progressed within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy urothelial carcinoma (UC)